F Senturk,
S Cakmak, M Gumusderelioglu… - Journal of Drug Delivery …, 2022 - Elsevier
Temozolomide (TMZ) is the first-line chemotherapeutic agent for the treatment of newly
diagnosed glioblastoma (GBM). However, chemoresistance, hydrolytic instability, and …